The anti-viral therapeutics market was valued at USD 51.26 billion in 2020, and it is expected to reach USD 67.76 billion in 2026, by registering a CAGR of 4.76% during the forecast period.
The sudden outbreak of the COVID-19 pandemic has made an optimis…
The Aptamers Market is expected to register a CAGR of 18.5% over the forecast period.
Globally, COVID-19 is an intractable health challenge resulting in an aberrant rate of morbidity and mortality. The mode of entry for SARS-CoV-2 into host cells occurs …
The biotechnology reagents market is expected to register a CAGR of nearly 7.4% over the forecast period.
In the context of COVID-19, government organizations in various countries, research institutes, and many biotech and pharmaceutical firms are focusi…